Abstract
We examined the influence of metabolic syndrome (MetS) on the relationship between arterial stiffness and the risk of coronary artery disease (CAD). In 396 subjects (age, 63±11 years) who underwent coronary angiography, multiple linear regression analysis demonstrated that the brachial-ankle pulse wave velocity (PWV), but not the presence of MetS, was a significant determinant of the number of diseased coronary arteries (β=0.10, p<0.05), even though both the brachial-ankle PWV and the number of diseased coronary arteries were higher in subjects with MetS (n=100) than in those without MetS (n=296). However, in subjects with MetS, multiple linear regression analysis demonstrated that the brachial-ankle PWV was not a significant determinant of the number of diseased coronary arteries. The brachial-ankle PWV values were classified into tertile ranges in subjects with and without MetS. The number of diseased coronary arteries increased significantly with an increase in the tertile number of the brachial-ankle PWV in the subjects without MetS (tertile 1=1.00±0.86, tertile 2=1.29±1.01, and tertile 3=1.45±1.05), but not in those with MetS. In conclusion, the results of this study suggest that arterial stiffness is a marker of the risk of CAD in subjects without MetS, whereas in subjects with MetS, the syndrome may directly produce clinically significant atherosclerotic stenosis of the coronary arteries independent of its significant promotion of the development of coronary atherosclerosis via an increase of arterial stiffness.
Similar content being viewed by others
Article PDF
References
Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384–3390.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG : Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085–2090.
Safar ME, Levy BI, Struijker-Boudier H : Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864–2869.
Zieman SJ, Melenovsky V, Kass DA : Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 1–12.
Cockcroft JR, Wilkinson IB : Large arterial stiffness: an important therapeutic target. J Hum Hypertens 2000; 14: 533–535.
McLeod AL, Uren NG, Wilkinson IB, et al: Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens 2004; 22: 363–368.
Imanishi R, Seto S, Toda G, et al: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71–78.
Weber T, Auer J, O'Rourke MF, et al: Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184–189.
Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association; National Heart, American, and Blood Institute : Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.
Tomiyama H, Koji Y, Yambe M, et al: Elevated C-reactive protein augments increased arterial stiffness in subjects with metabolic syndrome. Hypertension 2005: 45: 997–1003.
Tomiyama H, Hirayama Y, Hashimoto H, et al: The effects of changes in the metabolic syndrome detection status affect on arterial stiffening: a prospective study. Hypertens Res 2006; 29: 673–678.
Difinition and the diagnostic standard for metabolic syndrome—Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794–809 ( in Japanese).
Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359–364.
Koji Y, Tomiyama H, Ichihashi H, et al: Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 2004; 94: 868–872.
Cockcroft JR, Wilkinson IB, Evans M, et al: Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens 2005; 18: 1463–1467.
Kip KE, Marroquin OC, Kelley DE, et al: Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004; 109: 706–713.
Dart AM, Kingwell BA : Pulse pressure—a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37: 975–984.
Oliver JJ, Webb DJ : Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554–566.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koji, Y., Tomiyama, H., Yamada, J. et al. Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome. Hypertens Res 30, 243–247 (2007). https://doi.org/10.1291/hypres.30.243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.243
Keywords
This article is cited by
-
Retinal blood flow velocity in metabolic syndrome
Graefe's Archive for Clinical and Experimental Ophthalmology (2013)
-
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?
Journal of Human Hypertension (2008)